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Abstract
Few investigators have studied cognition over time in adults with heart failure (HF). A battery of
neuropsychological tests was administered to 279 adults with chronic systolic or diastolic HF at baseline,
three and six months. Growth mixture modeling (GMM) was used to model the measure anticipated to be
most sensitive, the digit symbol substitution task (DSST). We describe how and why the DSST patterns
change over time. Other measures of cognition were examined to identify consistency with the DSST
patterns. The sample was predominantly male (63.2%), Caucasian (62.7%), mean age 62 years. The best fit
GMM revealed two trajectories of DSST scores: Average processing speed group (40.5%) and Below Average
processing speed (59.9%). Neither group changed significantly over the six month study. Other measures of
cognition were consistent with the DSST patterns. Factors significantly associated with increased odds of
being in the Below Average processing speed group included older age, male gender, Non-Caucasian race, less
education, higher ejection fraction, high comorbid burden, excessive daytime sleepiness, and higher BMI. As
some of the factors related to cognitive impairment are modifiable, research is needed to identify interventions
to preserve and improve cognition in these patients.
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Few investigators have studied cognition over time in adults with heart failure (HF). A battery of neuropsychological tests was
administered to 279 adults with chronic systolic or diastolic HF at baseline, three and six months. Growth mixture modeling
(GMM) was used to model the measure anticipated to be most sensitive, the digit symbol substitution task (DSST). We describe
how and why the DSST patterns change over time. Other measures of cognition were examined to identify consistency with the
DSST patterns. The sample was predominantly male (63.2%), Caucasian (62.7%), mean age 62 years. The best fit GMM revealed
two trajectories of DSST scores: Average processing speed group (40.5%) and Below Average processing speed (59.9%). Neither
group changed significantly over the six month study. Other measures of cognition were consistent with the DSST patterns. Factors
significantly associated with increased odds of being in the Below Average processing speed group included older age, male gender,
Non-Caucasian race, less education, higher ejection fraction, high comorbid burden, excessive daytime sleepiness, and higher BMI.
As some of the factors related to cognitive impairment are modifiable, research is needed to identify interventions to preserve and
improve cognition in these patients.
1. Introduction
The prevalence of cognitive impairment in adults with
chronic heart failure (HF) is recognized as a factor contribut-
ing to complexity in caring for these patients [1]. A review
of studies from 2002 to 2007 estimated that approximately
25–50% of HF patients have impaired cognition [2]. Few
investigators have studied if and how cognition changes over
time in this population, however. Thus, the purposes of
this study were to identify patterns of cognition and how
those patterns change over a six-month period in adults
with chronic HF and to identify contributors to the patterns
identified.
Only six studies were located in which investigators
measured cognitive function of HF patients over intervals
of 18 weeks [3] to 10 years [4]. Two of the six studies
enrolled hospitalized HF patients [5, 6]. Three of the six
assessed cognitive functioning using screening instruments
such as the Mini-Mental Status Examination (MMSE) or
the Hodkinson Abbreviated Mental Test (AMT) rather than
standardized neuropsychological measures [5–7]. Only one
of these three screening studies found a change in function-
ing over time [5]. That study was a retrospective analysis
of data from 1,220 elderly hospitalized HF patients from 81
clinical sites in Italy collected during the 1990s. Cognitive
functioning was screened with the AMT before hospital
discharge when an ACE inhibitor was initiated for some
patients. After 12 months, ACE inhibitor prescription was
associated with significantly improved cognitive functioning
(odds ratio, 1.57; 95% confidence interval, 1.18–2.08), after
adjusting for baseline cognitive functioning and potential
confounding variables including systolic blood pressure.
Cognitive functioning did not improve among patients
without HF.
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Three of the six longitudinal studies used neuropsy-
chological measures of cognition. One of these studies
demonstrated that global cognitive functioning on the
Dementia Rating Scale (DRS) improved significantly, but
very modestly, over a 12-month period in patients with HF
compared to those with cardiovascular disease but not HF
[8]. Specifically, patients with HF improved in attention,
initiation/perseveration, and conceptualization over time.
The only predictor of improved global cognitive function
in the HF patients over time was higher diastolic blood
pressure at baseline (r = 0.38; P = .02). Perhaps the most
important finding from that study was to show that cognitive
functioning in HF is most likely to either increase slightly or
remain stable over a 12-month interval.
The second study using neuropsychological tests mea-
sured cognitive functioning in response to an exercise
training program [3]. Twenty HF patients (NYHA class III)
who completed an 18-week exercise training program were
compared to five HF patients who were unable to participate
in training. Six measures of cognitive functioning were
administered at baseline and at completion of the program.
Patients who exercised had significantly improved scores in
attention and psychomotor speed.
In the final study, data from 702 octogenarians from the
Swedish Twin Registry were analyzed using latent growth
curve modeling to assess performance over time in persons
with HF compared to those without HF [4]. Cognitive
testing was done five times between 1991 and 2002 using a
battery of neuropsychological measures of processing speed,
visuospatial ability, and short-term, episodic, and semantic
memory. Measures of episodic memory declined more over
time in the 13% of the sample with HF compared to those
without HF. There were no significant diﬀerences between
the groups in the other cognitive domains.
Together these studies suggest that episodic memory
declines over time but attention, initiation/perseveration,
conceptualization, and psychomotor speed may improve
over time in some HF patients. Factors associated with
improved cognition included receipt of an ACE inhibitor and
exercise training. The eﬀect of blood pressure on cognitive
change is unclear. Because data that address change in
cognition is so sparse and inconsistent, we analyzed data
obtained from a sample of adults with chronic HF in whom
a battery of neuropsychological measures was administered
at baseline, three and six months. This analysis began with
cognitive processing speed as measured by the Digit Symbol
Substitution Test (DSST) [9]. Previous research has shown
that DSST is among the most sensitive cognitive measures
to a variety of cognitive disturbances and declines rapidly
with advancing age [10]. Lower DSST scores were shown
to be associated with increased five-year mortality in the
Cardiovascular Health Study [11] and reduced information
processing speed using a similar measure (Symbol Digit
Modalities) is associated with cerebrovascular pathology and
cardiovascular risk [12, 13].
We used the DSST as an initial measure that we believed
would be highly sensitive to any cognitive impairment if it
was present. But, we were also interested in describing the
diﬀering neurocognitive patterns associated with the latent
groups established by DSST performance. It was possible,
though not highly likely, that our well-functioning group on
the DSST would show a more impaired profile in another
neurocognitive domain or that we would show diﬀerent
patterns of cognitive test performance in other measures.
Thus, DSST, with measures at three time points, was selected
as the primary study endpoint to assess longitudinal change.
But change in the other measures is described as well.
2. Methods
The methods used in this study have been described previ-
ously but, in brief, we conducted a prospective cohort study
with a consecutive sample of 280 adults with chronic HF
[14]. Subjects were enrolled from three outpatient settings
in the northeastern U.S. Only adults with chronic Stage C
HF (currently or previously symptomatic) of either systolic
or diastolic type were enrolled. All willing participants were
screened to assure adequacy of visual acuity, hearing, and
English fluency. We excluded individuals with severe cogni-
tive impairment as measured by the Telephone Interview of
Cognitive Status (TICS) [15]; nine individuals with a TICS
score below 24 were ineligible for enrollment. Thereafter,
we divided the sample into those with and without mild
cognitive impairment. The primary analysis focused on
the eﬀect of excessive daytime sleepiness on self-care, so
individuals living in a long-term care setting, working nights
or rotating shifts, or noted to have severe renal failure
requiring dialysis, major depressive illness, an imminently
terminal illness, plans to move out of the area, or a history
of serious drug or alcohol abuse within the past year were
excluded. Most of the data were collected in person during
home visits. Clinical information was abstracted from the
medical record. Data were collected between 2007 and 2010.
2.1. Measurement. A neuropsychological test battery mea-
suring the cognitive domains of processing speed, simple
and complex attention, working memory, verbal memory,
and crystallized cognitive ability was administered to all
participants at enrollment, three and six months. This six-
month interval was chosen to facilitate comparison with
our prior research and with the realization that a significant
proportion of the HF population dies in the first year
after diagnosis [16]. The battery included the Digit Symbol
Substitution Test [9] (DSST), whichmeasures processing and
psychomotor speed, the Psychomotor Vigilance Task (simple
attention) [17], the Trail Making Test B (complex attention)
[18], the Probed Recall Memory Task (working memory)
[10], and the Letter Number Sequencing test (short-term
memory) [9].
As noted above, the DSST was the focus of this analysis.
To complete the DSST, subjects were provided a series of
nonsequential numbers with blank boxes below. A key at
the top shows each unique number paired with a diﬀerent
symbol. Working in order, participants transcribe the appro-
priate symbol for each number in the blank boxes. Speed is
enhanced if the subject recalls the symbol that goes with each
letter rather than needing to look at the key. The number
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correctly completed in 120 seconds is measured. Higher
scores on the DSST indicate better cognitive processing
speed. Age-specific norms are available but in this study
the raw score was used in analysis because the analytic
technique requires continuous scores. Instead of using age-
specific norms, we included age as a covariate in the analysis
of determinants of cognitive processing speed.
Sociodemographic characteristics of age and gender
were measured by self-report. Household income was self-
reported in terms of adequacy; participants were asked
to consider how well their household lives on its income
(comfortable, have more than enough to make ends meet;
have enough to make ends meet; do not have enough to
make ends meet). Premorbid (i.e., crystallized) intelligence
was measured with the American National Adult Reading
Test (ANART) as a proxy for formal intelligence testing
[19]. On the ANART, subjects read a list of 50 phonetically
irregular words aloud. To estimate intelligence, we calculated
the number of errors made on the ANART and applied the
formulas [19].
To determine exercise frequency at enrollment, partici-
pants were asked how much exercise they had obtained in
the past week (none or fewer than 30 minutes, <1 hour
(minimal), or 1–3 hours (adequate)). We asked about only
the past week to avoid issues with recall. Body mass index
was calculated from height and weight in pounds at the time
of enrollment using the standard formula.
Blood pressure was measured during the enrollment
home visit and used to compute mean arterial pressure.
NYHA functional class was rated by a single cardiolo-
gist using information from a structured interview [20];
higher classes indicate worse functional status. Last known
left ventricular ejection fraction was abstracted from the
medical record. ACE inhibitor and beta blocker usage was
assessed (yes or no) from the list of medications obtained
from patients at the baseline visit. The 19-item Charlson
Comorbidity Index was used in analysis [21]. Responses
are weighted and summed. The total or categories (low,
moderate, or high) can be used in analysis, but we used the
categories because in the original validity testing the instru-
ment authors demonstrated that comorbidity categories
predicted mortality, complications, health care resource use,
length of hospital stay, discharge disposition, and cost [22].
Daytime sleepiness was measured with the Epworth
Sleepiness Scale (ESS); values greater ≥ 11 indicate excessive
daytime sleepiness [23]. Respondents rate the likelihood of
falling asleep in eight soporific situations using a 4-point
Likert scale ranging from never dozing (0) to high chance
of dozing (3). The ESS correlates significantly with the
frequency of apneas and is a validated research tool in the
assessment of excessive daytime sleepiness [24]. Test-retest
reliability (r = 0.82) and internal consistency (α = 0.88) have
been established in addition to its single factor structure [25].
Medication adherence was assessed with the Basel Assess-
ment of Adherence Scale (BAASIS), a structured interview
assessing general medication adherence over the past month
[26]. The BAASIS is a 4-item tool assessing compliance with
taking and timing dimensions of medication regimens as
well as the occurrence of drug holidays over the past four
weeks. A positive answer on any of the questions classifies a
patient as nonadherent with the medication regimen, a strict
definition of nonadherence that increases the sensitivity of
measurement. The BAASIS has established reliability and
validity [26].
2.2. Analysis. Standard descriptive statistics of frequency,
central tendency, and dispersion were used to describe the
sample. Comparisons of characteristics between observed
trajectories were made using Student’s t-tests, without
assuming equal variance, or χ2 analysis where appropriate.
StataMP v11 (College Station, Texas) was used for all descrip-
tive and comparative statistics. There is a growing body of
literature on eﬀectively capturing heterogeneous trajectories
of change over time [27–29]. Finite mixture models of
longitudinal data, such as growthmixturemodeling (GMM),
are used to identify common and distinct trajectories of
change [30]. GMM was used in this study to permit intra-
and inter-individual variability [31].
Mplus 6.1 software [32] was used to generate GMM,
using the expectation maximization (EM) algorithm and full
information maximum likelihood (FIML) for missing data,
assuming that data were missing at random (MAR) [33].
A maximum of three latent class trajectories was posited,
based on theoretical expectations and the limited sample size.
Our approach to model specification in GMM was based on
procedures explicated by Ram and colleagues [34]. Model
fit was assessed with Akaike information criterion (AIC);
the model with the lowest value was favored. Given the
potential sensitivity of the AIC to sample size and model
complexity, entropy also was used to gauge the accuracy of
classification. Entropy ranges from 0 to 1 with values closer
to 1 indicating better trajectory separation based on posterior
probabilities (average probability of belonging in “most
likely” trajectory near 1.0) [35, 36]. Model selection was also
assessed using the Lo-Mendell-Rubin adjusted likelihood
ratio test [LRT] with a significant result indicating the k
(as opposed to the k − 1) class solution is preferred [37].
Finally, the proportion of the sample in each trajectory (not
less than 5%) and parametric bootstrap LRT were used to
compare alternative models [38]. Univariate (unadjusted)
and multivariate (adjusted) logistic regression modeling was
then used to quantify the relationship between baseline
demographic and clinical characteristics and the likelihood
of membership in the trajectory with the lowest scores.
3. Results
One subject was missing data on the key variables, leaving a
sample of 279 available for this analysis. The sample was pre-
dominantly male (63.2%) and Caucasian (62.7%) (Table 1).
Themean age of the participants was 62 years. Family income
was suﬃcient in a large proportion (48.8%), and the average
education was approximately 14 years. Overall ANART error
scores suggest average general intelligence (estimated full
scale IQ (FSIQ) T Score = 47, 39-40th percentile). Most
participants were functionally compromised (76.3% NYHA
class III or IV). A slight majority (53.1%) had low-comorbid
burden based on Charlson Comorbidity Index categories.
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Figure 1: Two trajectories of change over time in DSST scores.
Many were sedentary (20.4%) or exercised less than 1 hour
weekly (36.9%). The average BMI was in the overweight (25–
29) range. Approximately 24% of the sample had significant
excessive daytime sleepiness.
Over the course of the study, average DSST scores
improved minimally from 53.4 ± 17.5 at baseline to 55.8
± 17.6 at three months and 58.1 ± 17.9 at six months,
and DSST scores were highly correlated over time (r > .83,
P < .001). The most informative and best fit GMM revealed
two trajectories of change in DSST scores (Figure 1). Model
AIC was 6112.5, entropy was 0.808, and the Lo-Mendell-
Rubin adjusted LRT (326.9, P < .001) and parametric
bootstrap LRT (346.2, P < .001) indicated dominant fit
with two trajectories over considering a single pattern of
change in DSST scores. The smaller trajectory (40.5% of
the sample, average posterior probability = 94.6%) identified
participants who had higher DSST scores throughout the
study, referred to as the average processing speed group. The
ANART estimated FSIQ for this group was in the average
range (T = 49, 44-45th percentile). The larger trajectory
(59.9% of the sample, average posterior probability =
94.1%) identified participants who had lower DSST scores
throughout the study, referred to as the below average
processing speed group. This group was also in the average
range of general intelligence on the ANART (T = 46, 34-35th
percentile).
There were several unadjusted diﬀerences between the
two observed trajectories (Table 1). For example, patients in
the average processing speed group were younger, had more
years of education, a lower mean arterial pressure, lower
BMI, and a slightly better, albeit not clinically meaningfully
diﬀerent, ANART score compared with patients in the below
average processing speed group. A greater proportion of
patients in the average processing speed group were female,
Caucasian, had suﬃcient or greater income, had adequate
exercise, had a low level of comorbidity, and took an
ACE inhibitor compared with patients in the below average
processing speed group.
In addition to the DSST, all other measures of cognition
were diﬀerent between the two groups at baseline. Each
measure demonstrated a very minor improvement in each
group over time. Diﬀerences in each measure of cognition
remained significant between the two groups at three and six
months (Table 2).
There were several factors that increased the likelihood
that patients would fit the below average processing speed
group individually and in the multivariate model (Table 3);
multivariate model χ2 = 139.9, P < .001; McFadden’s pseudo
R2 = 37.3%; Hosmer-Lemeshow LRT = 255.5, p.533; correct
classification rate = 79.1%; area under the curve = .876.
Factors significantly associated with increased odds of being
classified in the below average processing speed group in the
multivariate model included additional years of age, male
gender, non-Caucasian race, fewer years of education, higher
ejection fraction, high comorbid burden, excessive daytime
sleepiness, and higher values of BMI. Factors not related
to the below Average group were income, exercise, blood
pressure, ACE inhibitors, beta blockers, NYHA functional
class, premorbid intelligence, and medication adherence.
4. Discussion
Two distinct patterns of cognitive performance were identi-
fied in this sample of functionally limited but relatively young
HF patients. The below average processing speed group
scored consistently and significantly lower than the average
processing speed group on every measure of cognition, in
spite of evidence of average premorbid intellect in both
groups. The major finding of this study was that there was
little change in cognition over the six months of the study
in either of these groups. The minimal improvement seen
probably reflects the learning that typically occurs when
people take these tests multiple times. Many of the predictors
of those in the below average processing speed group were not
modifiable (higher age, male gender, non-Caucasian race,
fewer years of education, and high comorbid burden). How-
ever, excessive daytime sleepiness and BMI predicted group
membership and these factors are potentially modifiable, as
discussed below.
Other investigators have found some improvement in
cognition over time, although we did not. The study
by Zuccala´ and colleagues described in the introduction
enrolled hospitalized HF patients, treated them with ACE
inhibitors, and documented an improvement in overall
cognitive functioning after 12-months [5]. Our results could
diﬀer from theirs because we enrolled out-patients, most
were already on an ACE inhibitor, and we followed them
for only 6 months. The other studies that demonstrated
improvement in cognition tested an exercise intervention
[3] or followed patients for a longer period of time [8]. At
this point it does not appear that cognition can be greatly
improved but further research is needed to clarify this issue.
Building on the results of previous investigators we
tested the influence of ACE inhibitors, exercise, and blood
pressure on cognitive change over time and although these
three factors were significantly diﬀerent between the groups
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Table 1: Clinical and demographic characteristics of the two groups. Mean ± standard deviation or n (%) is reported.
Total sample
Average processing speed
(n = 114)
Below average processing speed
(n = 165) P value
Age (years) 62.1 ± 12.4 56.1 ± 12.1 66.3 ± 11.9 <.001
Male 179 (64.2) 62 (54.4) 117 (70.9) .005
Race/ethnicity
White 175 (62.7) 86 (75.4) 89 (53.9)
<.001
Non white 104 (37.3) 28 (24.6) 76 (46.1)
Income
.021More than enough 98 (35.1) 43 (37.7) 55 (33.3)
Suﬃcient 136 (48.8) 61 (53.5) 75 (45.5)
Less than enough 45 (16.1) 10 (8.8) 35 (21.2)
Years of education 13.9 ± 2.9 14.9 ± 3.1 13.2 ± 2.5 <.001
Body mass index (BMI) 31.0 ± 7.9 29.4 ± 7.5 32.0 ± 8.1 .006
Exercise
.002None 57 (20.4) 19 (16.7) 38 (23.0)
Minimal 103 (36.9) 32 (28.1) 71 (43.0)
Adequate 119 (42.7) 63 (55.3) 56 (34.0)
Charlson comorbidity severity
<.001Low 148 (53.1) 79 (69.3) 69 (41.8)
Moderate 101 (36.2) 32 (28.1) 69 (41.8)
High 30 (10.7) 3 (2.6) 27 (16.4)
NYHA functional class
Classes I and II 66 (23.7) 33 (28.9) 33 (20.0)
.188Class III 163 (58.4) 63 (55.3) 100 (60.6)
Class IV 50 (17.9) 18 (15.8) 32 (19.4)
Ejection fraction 35.5 ± 17.0 34.5 ± 16.0 36.2 ± 17.6 .404
ACE inhibitor 161 (57.7) 75 (65.8) 86 (52.1) .023
Beta blocker 258 (92.5) 107 (93.9) 151 (91.5) .466
Mean arterial pressure 84.7 ± 12.0 82.6 ± 11.4 86.1 ± 12.2 .016
Epworth sleepiness scale score ≥ 11 66 (23.7) 23 (20.2) 43 (26.1) .256
Basel medication adherence scale 0.96 ± 0.94 1.10 ± 0.95 0.90 ± 0.94 .193
ANART correct responses 56.8 ± 1.4 57.3 ± 1.3 56.4 ± 1.3 <.001
Digit symbol substitution task total score 53.4 ± 17.5 69.4 ± 11.0 42.3 ± 11.5 <.001
ACE: angiotensin converting enzyme; ANART: American National Adult Reading Test; NYHA: New York Heart Association.
in unadjusted analyses, none of these factors were useful
in predicting below average processing speed. Our results
probably diﬀer from those of prior investigators because of
the analytic technique used. That is, had we simply compared
the two groups our results would have supported those of
prior investigators. However, because we used a regression
analysis to identify the best predictors of below average
processing speed, some of the predictors were supplanted by
other better predictors.
The results of this study provide some support for the
conceptual model published by Bennett and colleagues [39].
They proposed that age, gender, comorbidity, hyperten-
sion, depression, medications, education, and circulatory
insuﬃciency (i.e., ejection fraction, duration of HF, NYHA
functional status, and oxygen saturation) contribute to
cognitive deficits in adults with chronic HF. Our results
corroborate their model with age, gender, comorbidity,
education, and ejection fraction identified as significantly
associated with increased odds of being classified in the
below average processing speed group. Noting that a high
Charlson Comorbidity score at enrollment predicted below
average processing speed suggests that processing speed is
influenced by illness burden, which supports prior results
[11, 40]. These results diﬀers from those of Pressler et al.
[41] who found that comorbidity was not associated with
cognitive changes, which may reflect the manner in which
the Charlson Comorbidity Index score was used in their
analysis (continuous score versus our use of categories) and
the longitudinal nature of our analyses.
We found that fewer years of education predicted below
average processing speed. These results support those of
Stern et al. who reported incident dementia data from
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Table 2: Change in indices of cognition by group. Mean ± standard deviation is reported.
Measure of cognition Enrollment 3 months 6 months F-test†
Digit symbol substitution task total score
Adequate processing speed 69.4 ± 11.1 71.5 ± 11.7 74.5 ± 10.7
F = 421.7‡
Below average processing speed 42.3 ± 11.5 44.0 ± 11.0 45.9 ± 11.1
Psychomotor vigilance task lapses
Adequate processing speed 3.8 ± 2.6 3.4 ± 2.8 3.5 ± 2.5
F = 23.9‡
Below average processing speed 5.8 ± 3.8 5.4 ± 3.4 5.1 ± 3.4
Trail making Test B time
Adequate processing speed 77.1 ± 32.8 74.6 ± 32.8 67.4 ± 31.2
F = 88.8‡
Below average processing speed 134.6 ± 61.7 128.7 ± 57.3 127.4 ± 57.5
Probed recall memory task (out of 4)
Adequate processing speed 2.6 ± 1.2 2.7 ± 1.2 2.9 ± 1.2
F = 45.5‡
Below average processing speed 1.6 ± 1.2 1.9 ± 1.3 2.0 ± 1.3
Letter number sequencing test
Adequate processing speed 10.4 ± 3.2 10.5 ± 3.4 10.8 ± 3.7
F = 51.0‡
Below average processing speed 7.5 ± 3.2 7.7 ± 3.1 7.7 ± 3.2
Number of cognitive tests with impairment
Adequate processing speed 1.3 ± 0.7 1.4 ± 0.8 1.3 ± 0.8
F = 29.8‡
Below average processing speed 2.0 ± 1.1 1.9 ± 1.1 1.7 ± 1.0
†
Test of between-subjects eﬀects; ‡P value < .0001.
Table 3: Factors predicting below average processing speed: unadjusted and adjusted odds.
Unadjusted odds ratio
(95% CI)
P value
Adjusted odds ratio
(95% CI)
P value
Age 1.08 (1.06–1.11) <.001 1.12 (1.08–1.16) <.001
Female 0.48 (0.30–0.81) .005 0.42 (0.21–0.85) .016
Non-Caucasian 2.62 (1.55–4.43) <.001 2.82 (1.21–6.55) .016
ANART-FSIQ 0.61 (0.50–0.74) <.001 0.75 (0.54–1.03) .078
Ejection fraction 1.01 (0.99–1.02) .410 1.02 (1.00–1.05) .033
Income 1.43 (1.01–2.04) .046 1.41 (0.83–2.41) .208
Charlson moderate∗ 2.47 (1.45–4.19) .001 1.81 (0.90–3.64) .096
Charlson high∗ 10.30 (2.99–35.45) <.001 9.65 (1.77–52.54) .009
ACE inhibitor 0.57 (0.35–0.93) .024 0.67 (0.23–1.34) .259
Beta blocker 0.71 (0.28–1.81) .467 1.55 (0.38–6.41) .543
Years of education 0.80 (0.73–0.88) <.001 0.85 (0.74–0.98) .024
Mean arterial pressure 0.99 (0.99–1.00) .296 0.99 (0.99–1.01) .179
NYHA 1.38 (0.99–1.92) .056 0.85 (0.52–1.38) .506
Excessive daytime
sleepiness
1.39 (0.79–2.48) .257 2.42 (1.05–5.53) .037
BMI 1.05 (1.01–1.08) .007 1.06 (1.01–1.11) .009
Basel adherence score 0.84 (0.65–1.09) .192 1.06 (0.61–1.22) .402
Exercise minimal† 1.11 (0.56–2.21) .768 0.92 (0.35–2.44) .865
Exercise adequate† 0.44 (0.23–0.86) .016 0.61 (0.24–1.58) .313
∗
Relative to low Charlson comorbid category.
†Relative to no exercise.
Key: ANART: American National Adult Reading Test; ACE Inhibitor: angiotensin converting enzyme inhibitor; NYHA: New York Heart Association.
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a follow-up study of 593 community-based, nondemented
individuals aged 60 years or older and identified low
education as a risk factor for dementia [42]. Stern dis-
cusses these findings in terms of cognitive reserve or
individual diﬀerences in the cognitive processes or neural
networks underlying task performance that allow some
people to cope better than others with damage to the brain
[43].
Excessive daytime sleepiness and BMI may be targets
of intervention to improve cognition. Excessive daytime
sleepiness may be a reflection of poor sleep quality and/or
sleep-disordered breathing, which are known to accentuate
the often subtle cognitive problems existing in persons
with HF [44, 45]. Sleep quality can be improved with
pharmaceutical agents, exercise [46], and cognitive behavior
therapy for insomnia [47]. Sleep-disordered breathing is
treatable with continuous positive airway pressure, which has
the added benefit of improving ejection fraction [48]. Body
mass index has not been studied as a predictor of cognition
previously in adults with HF, but higher BMI has been found
to be negatively associated with cognition in other groups
[49, 50].
A surprising finding of our study was that higher ejection
fraction was associated with below average processing speed,
a finding that contradicts those of others who have shown
that lower ejection fraction is associated with impaired
cognition [51–53]. It may be that an unaccounted for
interaction between ejection fraction and another factor
such as a medication could have influenced the direction
of eﬀect in this study. It should be noted, however, that in
some studies no relationship was identified between ejection
fraction and cognition [54, 55]. Further research is needed
to clarify the relationship between ejection fraction and
cognition.
Limitations of this analysis include the relatively young
age of the sample, considering that HF is most prevalent in
the eighth decade [16], adequate income, and an average
education of 14 years—all characteristics that suggest that
results from this sample may not be generalizable to the
general HF population. It is important to note that the
parent study used a cohort design in which individuals with
mild cognitive decline were preferentially sampled, which
may explain the two trajectories identified here. Also, as
these were out-patients, there was no guarantee that the
body weight reflected adipose or body mass rather than
fluid accumulation. Strengths of this study include the
longitudinal data, a relatively large sample size, and the
sophisticated analytic technique.
Future research is needed describing how cognition
changes or fails to change over time and what modifiable
factors are associated with an improvement. Clearly impaired
cognition is an issue in these patients, but we remain
uncertain what causes it, whether it is temporary or per-
manent, and how to intervene. Further research examining
the relationship between obesity and cognition is needed in
HF patients. Higher inflammatory markers are known to
increase brain and heart injury; cognition research including
biomarkers would further our understanding of how body
weight aﬀects cognition.
In summary, close to half of our sample demonstrated
average processing speed but most of the sample demon-
strated below average processing speed and no improve-
ment in cognition was seen over the six months of this
study. Eﬀorts are needed to identify interventions that can
eﬀectively prevent and perhaps reverse cognitive decline
after HF is diagnosed. Right now, exercise is the most
promising approach, as it has been demonstrated to induce
an increase in neural precursor cell activity and improve
cognition directly [56]. Exercise also could influence the
two modifiable predictors identified in this study: BMI and
excessive daytime sleepiness. Research testing interventions
aimed at improving cognition are urgently needed.
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